Wash-out of hepatocellular carcinoma: Quantitative region of interest analysis on CT

Annals of the Academy of Medicine Singapore

Volumn 40, Issue 6, 2011, Pages 269-275

  Tan, Cher Heng ^a   Thng, Choon Hua ^a   Low, Albert S C ^b   Tan, Veronique K M ^b   Hartono, Septian ^a   Koh, Tong San ^c   Goh, Brian K P ^b   Cheow, Peng Chung ^b   Tan, Yu Meng ^a   Chung, Alexander Y F ^b   Ooi, London L ^a,d   Earnest, Arul ^d,e   Chow, Pierce K H ^b,d  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Arterial hypervascularity; Region of interest analysis; Wash out

Indexed keywords

ADULT; AGED; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HOUNSFIELD UNIT; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; REGION OF INTEREST; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 79960118369     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002;35:72-8.
2. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-30.
3. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of Hepatocellular Carcinoma. Hepatology 2005;42:1208-36.
4. Hwang GJ, Kim MJ, Yoo HS, Lee JT. Nodular hepatocellular carcinomas: detection with arterial-, portal-, and delayed-phase images at spiral CT. Radiology 1997;202:383-8.
5. Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 2005;11:281-9.
6. Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003;52:1-8.
7. Yu SC, Yeung DT, So NM. Imaging features of hepatocellular carcinoma. Clin Radiol 2004;59:145-56.
8. Koh TS, Thng CH, Hartono S, Lee PS, Choo SP, Poon DY, et al. Dynamic contrast-enhanced CT imaging of hepatocellular carcinoma in cirrhosis: feasibility of a prolonged dual-phase imaging protocol with tracer kinetics modeling. Eur Radiol 2009;19:1184-96.
9. Oliver JH 3rd, Baron RL, Federle MP, Rockette HE Jr. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR Am J Roentgenol 1996;167:71-7.
10. Yan FH, Shen JZ, Li RC, Zeng MS, Wu D, Zhou KR, et al. Enhancement patterns of small hepatocellular carcinoma shown by dynamic MRI and CT. Hepatobiliary Pancreat Dis Int 2002;1:420-4.
11. Araki T, Itai Y, Furui S, Tasaka A. Dynamic CT densitometry of hepatic tumors. AJR Am J Roentgenol 1980;135:1037-43.
12. Koh TS, Thng CH, Lee PS, Hartono S, Rumpel H, Goh BC, et al. Hepatic metastases: in vivo assessment of perfusion parameters at dynamic contrast-enhanced MR imaging with dual-input two-compartment tracer kinetics model. Radiology 2008;249:307-20.